Abstract
Trichomoniasis (Trich) is one of the most commonly acquired STDs. “Trich” is often considered a “nuisance” infection, with symptoms of vaginal pruritis, dysuria, and, occasionally, pelvic pain. More is now known about potential health consequences of Trichomonas vaginalis. In addition to complications following certain gynecologic procedures, infection with this protozoan is associated with co-infection of other STDs and increases the individual’s risk of acquired HIV if exposed. Clinicians are charged to identify, educate, and treat patients and partners about this “not so benign” STD.
Keywords
- Human Immunodeficiency Virus
- Sexually Transmitted Infection
- Bacterial Vaginosis
- Vaginal Vault
- Vaginal Discharge
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cates Jr W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999;26:S2–7.
Gerbase AC, Rowley JT, Heymann DH, Berkley SF, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect. 1998;74:S12–6.
World Health Organization. Sexually Transmitted Infections Fact Sheet. Geneva, Switzerland: World Health Organization. 2004. Available from: www.who.int/reproductive-health/rtis/docs/sti_factsheet_2004.pdf. Accessed April 18, 2005.
Soper D. Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol. 2004;190:281–90.
Spence MR, Hollander DH, Smith J, McCaig L, Sewell D, Brockman M. The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis. 1980;7:168–71.
Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998;11:300–17.
Horowitz BJ, Mårdh P-A, editors. Vaginitis and Vaginosis. New York, NY: Wiley-Liss; 1999.
Hook III EW. Trichomonas vaginalis—no longer a minor STD. Sex Transm Dis. 1999;26:388–9.
Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7:95–102.
Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999;26:381–7.
Thomason JL, Gelbart SM. Trichomonas vaginalis. Obstet Gynecol. 1989;74:536–41.
Latif AS, Mason PR, Marowa E. Urethral trichomoniasis in men. Sex Transm Dis. 1987;14:9–11.
Mason PR, Forman L. Serological survey of trichomoniasis in Zimbabwe Rhodesia. Cent Afr J Med. 1980;26:6–8.
Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69:962–76.
Sweet RL, Gibbs RS. Infectious diseases of the female genital tract. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p. 339–40.
Lara-Torre E, Pinkerton JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear. Am J Obstet Gynecol. 2003;188:354–6.
Ledger WJ, Monif GR. A growing concern: inability to diagnose vulvovaginal infections correctly. Obstet Gynecol. 2004;103:782–4.
Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA. 1988;259:1223–7.
van Der Schee C, van Belkum A, Zwijgers L, et al. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol. 1999;37:4127–30.
Lobo TT, Feijo G, Carvalho SE, et al. A comparative evaluation of the Papanicolaou test for the diagnosis of trichomoniasis. Sex Transm Dis. 2003;30:694–9.
Borchardt KA, Li Z, Zhang MZ, Shing H. An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test. Genitourin Med. 1996;72:132–5.
Weston TE, Nicol CS. Natural history of trichomonal infection in males. Br J Vener Dis. 1963;39:251–7.
Durel P, Roiron V, Siboulet A, Borel LJ. Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 RP. Br J Vener Dis. 1960;36:21–6.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006; 55(RR-11):52–54. Available from: http://www.cdc.gov/std/treatment/. Accessed Nov. 24, 2006.
Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis. 2001;33:1341–6.
Spence MR, Harwell TS, Davies MC, Smith JL. The minimum single oral metronidazole dose for treating trichomoniasis: a randomized, blinded study. Obstet Gynecol. 1997;89:699–703.
Hager WD, Brown ST, Kraus SJ, Kleris GS, Perkins GJ, Henderson M. Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens. JAMA. 1980;244:1219–20.
Tidwell BH, Lushbaugh WB, Laughlin MD, Cleary JD, Finley RW. A double-blind placebo-controlled trial of single-dose intravaginal versus single-dose oral metronidazole in the treatment of trichomonal vaginitis. J Infect Dis. 1994;170:242–6.
Smilack JD, Wilson WR, Cockerill III FR. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin Proc. 1991;66:1270–80.
Flagyl. Prescribing Information. Chicago, IL: Pfizer Inc., 2004.
Pearlman MD, Yashar C, Ernst S, Solomon W. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole. Am J Obstet Gynecol. 1996;174:934–6.
Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med. 2001;46:545–9.
Pattman RS. Recalcitrant vaginal trichomoniasis. Sex Transm Infect. 1999;75:127–8.
Feola DJ, Thornton AC. Metronidazole-induced pancreatitis in a patient with recurrent vaginal trichomoniasis. Pharmacotherapy. 2002;22:1508–10.
Cotch MF, Pastorek II JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24:353–60.
Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995;172:525–9.
Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol. 1993;82:348–52.
National Institute of Allergy and Infectious Diseases. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Washington, DC: National Institutes of Health, Department of Health Services, 2001. Available from: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf. Accessed Nov. 24, 2006.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Moore, A. (2013). Trichomoniasis. In: Skolnik, N., Clouse, A., Woodward, J. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-499-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-499-9_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-498-2
Online ISBN: 978-1-62703-499-9
eBook Packages: MedicineMedicine (R0)